Akero Therapeutics (AKRO) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts AKRO Hot Sheet
Join SI Premium – FREE
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.60), $0.01 better than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- AbbVie updates 2026 EPS guidance after $291M IPR&D charge
- Mizuho Resumes Spire (SR) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
